IMMUNOSIGNATURING: A PATH TO EARLY DIAGNOSIS AND HEALTH MONITORING
Health is a complex state that represents the continuously changing outcome of nearly all human activities and interactions. The invention provides efficient methods and arrays for health monitoring, diagnosis, treatment, and preventive care. The invention monitors a broad range of identifying molecules from a subject, such as circulating antibodies, and the invention evaluates a pattern of binding of those molecules to a peptide array. The characterization of the pattern of binding of such molecules to a peptide array with the methods of the invention provide a robust measure of a state of health of a subject.
1 . A method of health monitoring, the method comprising:
a) contacting a complex biological sample to a peptide array, wherein the peptide array comprises different peptides capable of off-target binding of at least one antibody in the biological sample;
b) measuring the off-target binding of the antibody to a plurality of different peptides in the peptide array to form an immunosignature; and
c) associating the immunosignature with a state of health.
2 . The method of claim 1 , wherein the different peptides on the peptide array are between 8 and 35 residues in length.
3 . (canceled)
4 . The method of claim 1 , wherein the different peptides on the peptide array have an average spacing ranging from 2-4 nm.
5 - 6 . (canceled)
7 . The method of claim 1 , wherein the different peptides bind to the molecule with an association constant in the range of 10 3 to 10 6 M −1 .
8 - 9 . (canceled)
10 . The method of claim 1 , wherein the different peptides comprise peptide mimetics.
11 . The method of claim 1 , wherein the different peptides have random amino acid sequences.
12 . The method of claim 1 , wherein the different peptides comprise non-natural amino acids.
13 - 36 . (canceled)
37 . A method of diagnosis, the method comprising:
a) receiving a complex biological sample from a subject;
b) contacting the complex biological sample to a peptide array, wherein the peptide array comprises different peptides capable of off-target binding of at least one antibody in the biological sample;
c) measuring the off-target binding of the antibody to a group of different peptides in the peptide array to form an immunosignature; and
d) diagnosing a condition based on the immunosignature.
38 . The method of claim 37 , wherein the different peptides on the peptide array are between 8 and 35 residues in length.
39 . (canceled)
40 . The method of claim 37 , wherein the different peptides on the peptide array have an average spacing ranging from 2-4 nm.
41 . The method of claim 37 , wherein the different peptides on the peptide array have an average spacing ranging from 3-6 nm.
42 . The method of claim 37 , wherein the different peptides bind to the molecule with an association constant of about 10 3 M −1 .
43 . The method of claim 37 , wherein the different peptides bind to the molecule with an association constant in the range of 10 3 to 10 6 M −1 .
44 . (canceled)
45 . (canceled)
46 . The method of claim 37 , wherein the different peptides comprise peptide mimetics.
47 . The method of claim 37 , wherein the different peptides have random amino acid sequences.
48 . The method of claim 37 , wherein the different peptides bind a paratope.
49 . An array comprising a plurality of in-situ synthesized polymers of variable lengths immobilized to different locations on a solid support, wherein the in-situ synthesis of polymers comprises the steps of:
a. adding a first monomer to a pre-determined fraction of locations on the solid support;
b. adding a second monomer to a pre-determined fraction of locations on the solid support, wherein the pre-determined fraction of locations for the second monomer includes locations containing the first monomer and locations with no monomer;
c. adding a third monomer to a pre-determined fraction of locations on the solid support, wherein the pre-determined fraction of locations for the second monomer includes locations containing the first and second monomer, locations containing the second monomer and locations containing no monomer; and
d. repeating steps a-c with a defined set of monomers until the polymers reach a desired average length and the sum of the fractions total at least 100%.
50 - 51 . (canceled)
52 . The array of claim 49 , wherein the monomers are chosen from the group consisting of amino acids, nucleic acids, and peptide nucleic acids.
53 - 56 . (canceled)
57 . The array of claim 49 , wherein the polymers have an average length of not less than 5 residues.
58 . The array of claim 49 , wherein at least 5% of the polymers have a length of at least 12 residues.
59 - 61 . (canceled)
62 . The array of claim 49 , wherein the number of polymers is greater than 3,000.
63 - 83 . (canceled)